Skip to Content

POTTERS ECZEMA OINTMENT

Active substance(s): BENZOIC ACID / CHICKWEED SOFT EXTRACT 100=42 / SALICYLIC ACID / ZINC OXIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
SUMMARY OF PRODUCT CHARACTERISTICS

1

NAME OF THE MEDICINAL PRODUCT
Potter’s Eczema Ointment

2

QUALITATIVE AND QUANTITATIVE COMPOSITION
Zinc Oxide BP 8.7 % w/w; Salicylic Acid BP 2.0 % w/w; Benzoic Acid BP
0.23 % w/w; Soft Extract Chickweed 100=42 6.3 % w/w

3

PHARMACEUTICAL FORM
Ointment

4

CLINICAL PARTICULARS

4.1

Therapeutic indications
For the symptomatic relief of eczema.

4.2

Posology and method of administration
Adults, Elderly and Children over 5: Apply twice daily to the areas affected.
Not for children under 5.

4.3

Contraindications
None.

4.4

Special warnings and precautions for use
Remove jewellery.
Keep medicines away from children.

4.5

Interaction with other medicinal products and other forms of interaction
None known.

4.6

Fertility, Pregnancy and lactation
Not recommended.

4.7

Effects on ability to drive and use machines
None.

4.8

Undesirable effects
None.

4.9

Overdose
No cases known.

5

PHARMACOLOGICAL PROPERTIES

5.1

Pharmacodynamic properties
Zinc Oxide is astringent. Salicylic and Benzoic Acids are keratolytic.
Chickweed extract is emollient.

5.2

Pharmacokinetic properties
No information available.

5.3

Preclinical safety data
No information available.

6

PHARMACEUTICAL PARTICULARS

6.1

List of excipients
Hydrous Lanolin, Vanillin, Lard, Yellow Soft Paraffin.

6.2

Incompatibilities
None.

6.3

Shelf life
Three years.

6.4

Special precautions for storage
None.

6.5

Nature and contents of container
Double-wall polyethylene pot with hard plastic screwcap: 28 g.

Glass jar with hard plastic screwcap: 28 g.
Hard plastic jar with hard plastic screwoap: 500 g.

6.6

Special precautions for disposal
Not applicable.

7

MARKETING AUTHORISATION HOLDER
Vifor Pharma UK Ltd
1 Botanic Court,
Martland Park,
Wigan,
WN5 0JZ,
UK.
Trading as: Potters, Wigan WN5 0JZ

8

MARKETING AUTHORISATION NUMBER(S)
PL 33656/0010

9

DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
31/08/1984 / 27/03/2003

10

DATE OF REVISION OF THE TEXT
14/07/2012

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide